Role of Punarvadi Kashaya with Shodhita Guggulu and Triphaladi Kashaya with Shodhita Guggulu In Granthi or Ovarian cyst

A randomized open labelled clinical study on the efficacy of Punarnavadi Kashaya with Shodhita Guggulu in Granthi with special reference to Ovarian cyst and its comparison with the Efficacy of Triphaladi Kashaya with Shodhita Guggulu - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/105480

Enrollment

Registered

2026-03-06

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E289- Ovarian dysfunction, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Participants between the age group of 18 to 50 years irrespective of their marital status,parity, religion and socio-economic status. 2. Participants diagnosed with ovarian cyst by the Sonography. 3. Participants with ovarian cyst experiencing lower abdominal pain, breast tenderness. 4. Participants with ovarian cyst having regular or irregular menstrual cycle. 5. Participants with Asymptomatic ovarian cyst. 6. Participants with single or multiple or unilateral or bilateral and unilocular cyst. 7. Participants with ovarian cyst size less then or equal to 7 cm. 8. Participants with follicular cyst, corpus luteum, thica lutein, endometrial cyst, PCOS and Haemorrhagic cyst

Exclusion criteria

Exclusion criteria: 1. Participants who are Pregnant and Lactating women 2 Participants with Hb less than 10 Parcent 3.Participants with Granulosa lutein cyst and Neoplastic ovarian enlargement (benign or malignant). 4. Participants Know case of hypertension, diabetes mellitus, tuberculosis, other chronic systematic disease. 5. Participants with severe pain in the abdomen. 6. Participants with Oral contraceptive pills consumption during the last three months.

Design outcomes

Primary

Measure	Time frame
Significant reduction or resolution in the size of the cyst will be established by the USG in the management of Granthi with special respect to Ovarian cyst. Timepoint: Trial Period 60 days Assessment on 0th day 60th day and 90th day Fallow Up On 90th day Total Study duration 90 days	—

Secondary

Measure	Time frame
Significant reduction or resolution in the size of the cyst will be established by the USG in the management of Granthi with special respect to Ovarian cyst. Timepoint: Trial Period 60 days Assessment on 0th day 60th day and 90th day Fallow Up On 90th day Total Study duration 90 days	—

Countries

India

Contacts

Public ContactDr Preeti Kakasab Khot

Sri Sri College of Ayurvedic Science and Research

rampursspatil@gmail.com9742193553

Outcome results